British technology company Paragraf, a Cambridge University spinout, is being sued by former shareholders of US tech firm Cardea. The lawsuit, filed in Delaware, claims that Paragraf founder Simon Thomas and other executives misled American investors by exaggerating the company's capabilities to produce graphene electronic chips during a 2023 takeover.
The former Cardea shareholders allege they were duped into accepting a takeover offer in exchange for Paragraf shares said to be worth £29.8 million, but which they claim were actually worth only £5.4 million. They describe the conduct as 'fraud and deceit on the sellers of Cardea stock'.
The lawsuit also accuses Dr Thomas of operating Paragraf on a 'fake it until you make it' principle, with executives allegedly making 'intentional misrepresentations, half-truths and material omissions'. Cardea shareholders claim they were told Paragraf could manufacture graphene devices on an industrial scale, with forecast revenues significantly higher than actual revenues reported in 2023 and 2024.
A spokesperson for Paragraf stated, 'We are aware of a claim brought by the Cardea Stockholder Group. We believe it is without merit, and our lawyers have asked the court to dismiss it. As this is an ongoing legal matter, we cannot comment further. Paragraf continues to perform strongly, and our focus remains on our customers, our staff, and our plans for growth.'